Advisor profile · Tech M&A Deal Index

Houlihan Lokey: credited tech M&A deals

Deals in the ProCloser Tech & SaaS M&A Deal Index where Houlihan Lokey was named as an advisor in a public source. Back to the advisor league.

Houlihan Lokey Preferred is an M&A advisory firm publicly credited on 8 deals in the ProCloser Tech M&A Deal Index (6 sell-side, 2 buy-side), announced between Jan 22, 2026 and Sep 30, 2026.

The largest disclosed deal is Thoma Bravo's acquisition of Accelerant for $4 billion (News).

Sectors: Fintech (2), SaaS (2), Healthtech (2), Vertical AI (1), Data infrastructure (1). 2 of 8 credited deals disclosed a value.

Houlihan Lokey is a ProCloser preferred firm: it is ranked #1 in The 9 Best M&A Advisors for Lending Tech and Specialty Finance in 2026, and also tops Best M&A Advisory Firms for Mid-Sized Companies (2025-2026 Rankings).

See Houlihan Lokey's full ProCloser directory profile →

Last updated Nov 18, 2026.

8
Credited deals
6 / 2
Sell-side / buy-side
5
Sectors
Jan 2026 to Sep 2026
Date range
$4.06B
Disclosed total
$2.03B
Median disclosed
#7
League rank of 174 firms
#17
Value rank of 58 firms

Houlihan Lokey sits at #7 of 174 in the advisor league by credited deals, while the median firm in the league holds 1 credited deal. By total disclosed value of credited deals, Houlihan Lokey ranks #17 of 58 among firms with at least one priced deal. Ties share the better rank. The targets in Houlihan Lokey's record, oldest first, are Anova, Apploi, CareSeed, Sudolabs, Accelerant, Queue-It, Icario and TRAFiX. The first credit in Houlihan Lokey's record is Anova on Jan 22, 2026 and the latest is TRAFiX on Sep 30, 2026, a span of 251 days. That works out to one credited deal every 36 days on average, and the longest quiet stretch was 128 days between Apploi and CareSeed. The sections below walk through each of those deals, the buyers and co-advisors involved, and how Houlihan Lokey compares inside every sector it is credited in, all computed from the rows of the index.

Download CSV JSON Open dataset page Disclosed values by sector RSS feed Open data, CC BY 4.0. Cite as "ProCloser Tech M&A Deal Index" with a link.

Credited deals

Where Houlihan Lokey advised the buyer, the credit appears as "Buy-side" beneath the sell-side advisor cell. Values only where publicly disclosed; every row links to its source.

8 deals where Houlihan Lokey was publicly credited, newest first, with disclosed values and sources.
DateTargetAcquirerBuyer typeSectorGeo (target → acquirer)ValueSell-side advisorSource
TRAFiXequities order and execution management systemsTrading Technologies InternationalStrategicFintechn/a → n/aUndisclosedHoulihan Lokey Preferred, Marks BaughanBuy-side: Berenson & CompanyNews
Icariomember engagement and behavioral health platformVitality Group InternationalPublic companyHealthtechUS → US$59.5Mupfront cash plus contingent earn-out, up toCain Brothers, a division of KeyBanc Capital MarketsBuy-side: Houlihan Lokey PreferredNews
Queue-Itvirtual waiting room and queue management softwareTHLPrivate equitySaaSDK → USUndisclosedHoulihan Lokey PreferredNews
Accelerantdata-driven risk exchange for specialty insuranceThoma BravoPrivate equityFintechUS → US$4Benterprise value more than $4 billion; all-cash at $20.25 per shareMorgan Stanley, Houlihan Lokey PreferredBuy-side: BMO Capital Markets, Wells FargoNews
Sudolabscustom agentic AI systems, enterprise consultingEldridgeStrategicVertical AISK → USUndisclosedHoulihan Lokey PreferredNews
CareSeedHEDIS quality reporting and analytics for payersSagilityStrategicHealthtechUS → n/aUndisclosedHoulihan Lokey PreferredNews
Apploihealthcare hiring and workforce management softwareViventiumStrategicSaaSUS → USUndisclosedHoulihan Lokey PreferredPress release
AnovaIIoT remote asset monitoring platformAurora Capital PartnersPrivate equityData infrastructureUS → USUndisclosedBaird PreferredBuy-side: Houlihan Lokey PreferredPress release

Firms in gold are ProCloser preferred firms: each is ranked #1 in one of our best-advisor guides. Other advisors are named as credited in the source. Source links open the original announcement. Credits for Houlihan Lokey appear only where Houlihan Lokey was named in a public announcement.

Houlihan Lokey, deal by deal, newest first

One paragraph for each of the 8 deals credited to Houlihan Lokey, written from the fields of the row and the linked source. A clause appears only when the index holds that field.

Trading Technologies International acquires TRAFiX (sell-side, Sep 30, 2026)

Houlihan Lokey is credited as sell-side advisor on this deal, which means Houlihan Lokey advised TRAFiX on the sale to Trading Technologies International. Trading Technologies International acquired TRAFiX, a provider of equities and equity options order and execution management systems, for undisclosed terms. The announcement Houlihan Lokey was credited on is dated Sep 30, 2026, and the index files TRAFiX under Fintech in the sub-sector of equities order and execution management systems. In Houlihan Lokey's record the tags attached to TRAFiX are trading platform, order management, equities and fix connectivity. The index classes Trading Technologies International as a strategic buyer. No price was disclosed for TRAFiX, so no figure is entered for it. Credited beside Houlihan Lokey on the same side: Marks Baughan. Berenson & Company advised the other side of the table from Houlihan Lokey. In the date order of Houlihan Lokey's own record this is credit 8 of 8, announced 27 days after the Icario credit, and credit 2 of 2 in Fintech. The announcement behind the TRAFiX credit: Trading Technologies Acquires TRAFiX To Expand Multi-Asset Trading Platform, Pulse 2.0 (news). The index rates this row high confidence.

Vitality Group International acquires Icario (buy-side, Sep 3, 2026)

Houlihan Lokey is credited as buy-side advisor on this deal, which means Houlihan Lokey advised Vitality Group International on the purchase of Icario. Vitality Group International acquired Icario Holdco Incorporated, a health engagement and behavioral change platform, for up to $59.5 million. The announcement Houlihan Lokey was credited on is dated Sep 3, 2026, and the index files Icario under Healthtech in the sub-sector of member engagement and behavioral health platform. In Houlihan Lokey's record the tags attached to Icario are payer engagement, population health, member activation and behavioral health. The index classes Vitality Group International as a public company buyer. Icario is based in the United States and Vitality Group International in the United States, so the index treats it as a domestic deal. The price disclosed for Icario is $59.5 million, with this value note: upfront cash plus contingent earn-out, up to. Cain Brothers, a division of KeyBanc Capital Markets advised the other side of the table from Houlihan Lokey. In the date order of Houlihan Lokey's own record this is credit 7 of 8, announced 16 days after the Queue-It credit, and credit 2 of 2 in Healthtech. The announcement behind the Icario credit: Vitality’s Acquisition of Icario: Strategic Convergence in Payer Engagement, healthcare.digital (news). The index rates this row high confidence.

THL acquires Queue-It (sell-side, Aug 18, 2026)

Houlihan Lokey is credited as sell-side advisor on this deal, which means Houlihan Lokey advised Queue-It on the sale to THL. THL agreed to acquire Queue-It from GRO Capital, a virtual waiting room and queue management software provider, for undisclosed terms. The announcement Houlihan Lokey was credited on is dated Aug 18, 2026, and the index files Queue-It under SaaS in the sub-sector of virtual waiting room and queue management software. In Houlihan Lokey's record the tags attached to Queue-It are queue management, virtual waiting room, traffic management and e-commerce infrastructure. The index classes THL as a private equity buyer. Queue-It is based in Denmark and THL in the United States, a US and Europe cross-border deal. No price was disclosed for Queue-It, and the index leaves the figure blank. The source names no advisor other than Houlihan Lokey on the Queue-It deal. In the date order of Houlihan Lokey's own record this is credit 6 of 8, announced 5 days after the Accelerant credit, and credit 2 of 2 in SaaS. The announcement behind the Queue-It credit: Exclusive: THL to acquire Queue-It from GRO Capital as ‘agentic commerce’ grows, pehub.com (news). The index rates this row medium confidence.

Thoma Bravo acquires Accelerant (sell-side, Aug 13, 2026)

Houlihan Lokey is credited as sell-side advisor on this deal, which means Houlihan Lokey advised Accelerant on the sale to Thoma Bravo. Thoma Bravo agreed to acquire Accelerant, a data-driven risk exchange platform for specialty insurance, for $20.25 per share, an enterprise value of more than $4 billion. The announcement Houlihan Lokey was credited on is dated Aug 13, 2026, and the index files Accelerant under Fintech in the sub-sector of data-driven risk exchange for specialty insurance. In Houlihan Lokey's record the tags attached to Accelerant are insurtech, risk exchange, specialty insurance and underwriting data. The index classes Thoma Bravo as a private equity buyer. Accelerant is based in the United States and Thoma Bravo in the United States, so the index treats it as a domestic deal. The price disclosed for Accelerant is $4 billion, with this value note: enterprise value more than $4 billion; all-cash at $20.25 per share. Credited beside Houlihan Lokey on the same side: Morgan Stanley. BMO Capital Markets and Wells Fargo advised the other side of the table from Houlihan Lokey. In the date order of Houlihan Lokey's own record this is credit 5 of 8, announced 3 days after the Sudolabs credit, and credit 1 of 2 in Fintech. The announcement behind the Accelerant credit: Accelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo, Thoma Bravo (news). The index rates this row high confidence.

Eldridge acquires Sudolabs (sell-side, Aug 10, 2026)

Houlihan Lokey is credited as sell-side advisor on this deal, which means Houlihan Lokey advised Sudolabs on the sale to Eldridge. Eldridge acquired a significant ownership stake in Sudolabs, a developer of custom agentic AI systems, for undisclosed terms. The announcement Houlihan Lokey was credited on is dated Aug 10, 2026, and the index files Sudolabs under Vertical AI in the sub-sector of custom agentic AI systems, enterprise consulting. In Houlihan Lokey's record the tags attached to Sudolabs are agentic ai, ai deployment, enterprise ai and llm orchestration. The index classes Eldridge as a strategic buyer. Sudolabs is based in Slovakia and Eldridge in the United States, a US and Europe cross-border deal. No price was disclosed for Sudolabs, so the value stays blank here. The source names no advisor other than Houlihan Lokey on the Sudolabs deal. In the date order of Houlihan Lokey's own record this is credit 4 of 8, announced 59 days after the CareSeed credit, and the only Vertical AI credit for Houlihan Lokey. The announcement behind the Sudolabs credit: Eldridge Acquires Stake in Sudolabs to Accelerate U.S. AI Expansion, citybiz (news). The index rates this row high confidence.

Sagility acquires CareSeed (sell-side, Jun 12, 2026)

Houlihan Lokey is credited as sell-side advisor on this deal, which means Houlihan Lokey advised CareSeed on the sale to Sagility. Sagility acquired CareSeed, a healthcare analytics company specializing in NCQA-certified HEDIS quality reporting, for undisclosed terms. The announcement Houlihan Lokey was credited on is dated Jun 12, 2026, and the index files CareSeed under Healthtech in the sub-sector of HEDIS quality reporting and analytics for payers. In Houlihan Lokey's record the tags attached to CareSeed are hedis, quality reporting, medicare advantage, healthcare analytics and chart abstraction. The index classes Sagility as a strategic buyer. CareSeed is based in the United States; the index records no buyer country. No price was disclosed for CareSeed, and the index leaves the figure blank. The source names no advisor other than Houlihan Lokey on the CareSeed deal. In the date order of Houlihan Lokey's own record this is credit 3 of 8, announced 128 days after the Apploi credit, and credit 1 of 2 in Healthtech. The announcement behind the CareSeed credit: Sagility Acquires CareSeed To Expand AI-Powered Quality Operations And Medicare Advantage Capabilities, Pulse 2.0 (news). The index rates this row high confidence.

Viventium acquires Apploi (sell-side, Feb 4, 2026)

Houlihan Lokey is credited as sell-side advisor on this deal, which means Houlihan Lokey advised Apploi on the sale to Viventium. Viventium acquired Apploi, a healthcare hiring and workforce management software platform, for undisclosed terms. The announcement Houlihan Lokey was credited on is dated Feb 4, 2026, and the index files Apploi under SaaS in the sub-sector of healthcare hiring and workforce management software. In Houlihan Lokey's record the tags attached to Apploi are hr tech, healthcare staffing, recruiting, scheduling and workforce management. The index classes Viventium as a strategic buyer. Apploi is based in the United States and Viventium in the United States, so the index treats it as a domestic deal. No price was disclosed for Apploi, so no figure is entered for it. The source names no advisor other than Houlihan Lokey on the Apploi deal. In the date order of Houlihan Lokey's own record this is credit 2 of 8, announced 13 days after the Anova credit, and credit 1 of 2 in SaaS. The announcement behind the Apploi credit: Viventium Acquires Apploi to Create a Leading Nationally Scaled, Healthcare-Exclusive Human Capital Management Platform (press release). The index rates this row high confidence.

Aurora Capital Partners acquires Anova (buy-side, Jan 22, 2026)

Houlihan Lokey is credited as buy-side advisor on this deal, which means Houlihan Lokey advised Aurora Capital Partners on the purchase of Anova. Aurora Capital Partners acquired Anova, a global IIoT provider for industrial asset monitoring, for undisclosed terms. The announcement Houlihan Lokey was credited on is dated Jan 22, 2026, and the index files Anova under Data infrastructure in the sub-sector of IIoT remote asset monitoring platform. In Houlihan Lokey's record the tags attached to Anova are iiot, remote monitoring, industrial, telemetry and cloud platform. The index classes Aurora Capital Partners as a private equity buyer. Anova is based in the United States and Aurora Capital Partners in the United States, so the index treats it as a domestic deal. No price was disclosed for Anova, and the index never estimates one. Baird advised the other side of the table from Houlihan Lokey. In the date order of Houlihan Lokey's own record this is credit 1 of 8, the earliest credit, and the only Data infrastructure credit for Houlihan Lokey. The announcement behind the Anova credit: Aurora Capital Partners Acquires Anova, a Leading Global Provider of IIoT Solutions (press release). The index rates this row high confidence.

Houlihan Lokey in charts

Houlihan Lokey: deals by sector

Fintech2Healthtech2SaaS2Data infrastructure1Vertical AI1
Fintech leads with 2 of 8 credited deals (25%), across 5 sectors.
Data table
SectorHoulihan Lokey deals (share)
Fintech2 (25%)
Healthtech2 (25%)
SaaS2 (25%)
Data infrastructure1 (12%)
Vertical AI1 (12%)

Houlihan Lokey: deals by buyer type

Strategic4Private equity3Public company1
Strategic buyers account for 4 of 8 deals (50%); 3 buyer types appear.
Data table
Buyer typeHoulihan Lokey deals (share)
Strategic4 (50%)
Private equity3 (38%)
Public company1 (12%)

Houlihan Lokey: deals by quarter

2Q1 20261Q2 20265Q3 2026
Q3 2026 is the busiest quarter with 5 credited deals. Quarters with no credited deal between the first and last announcement show as zero.
Data table
QuarterHoulihan Lokey deals
Q1 20262
Q2 20261
Q3 20265

Houlihan Lokey: deals by size bucket

1$20M to $200M1Over $1B6Undisclosed
Undisclosed is the most common size bucket (6 of 8 deals). Deals without a public price sit in the undisclosed bucket and are never estimated.
Data table
Size bucketHoulihan Lokey deals
$20M to $200M1
Over $1B1
Undisclosed6

Who Houlihan Lokey worked with

Co-advisors

4 of the 8 deals credited to Houlihan Lokey name at least one other advisor, and the other 4 name Houlihan Lokey alone. 7 other firms appear next to Houlihan Lokey: 2 on the same side and 5 across the table. Marks Baughan is the most frequent counterpart, sharing 1 deal with Houlihan Lokey.

FirmWith Houlihan Lokey on one sideAcross the table from Houlihan LokeyShared deals
Marks Baughan10TRAFiX
Morgan Stanley10Accelerant
Baird01Anova
Berenson & Company01TRAFiX
BMO Capital Markets01Accelerant
Cain Brothers, a division of KeyBanc Capital Markets01Icario
Wells Fargo01Accelerant

Acquirers

The 8 deals credited to Houlihan Lokey involve 8 distinct acquirers. Each acquirer appears once, so Houlihan Lokey has no repeat buyer in its credited deals. By buyer type the mix behind Houlihan Lokey's deals is strategic (4), private equity (3) and public company (1).

AcquirerBuyer typeDeals with Houlihan LokeyLargest disclosedTargets
Thoma BravoPrivate equity1$4BAccelerant
Vitality Group InternationalPublic company1$59.5MIcario
Aurora Capital PartnersPrivate equity1UndisclosedAnova
EldridgeStrategic1UndisclosedSudolabs
SagilityStrategic1UndisclosedCareSeed
THLPrivate equity1UndisclosedQueue-It
Trading Technologies InternationalStrategic1UndisclosedTRAFiX
ViventiumStrategic1UndisclosedApploi

Sector context for Houlihan Lokey

How the credits of Houlihan Lokey compare with the whole index in each sector where Houlihan Lokey is credited.

Fintech: Houlihan Lokey against the sector

Houlihan Lokey is credited on 2 of the 28 advised Fintech deals, a 7.1% share, which puts Houlihan Lokey #4 of 41 (tied with 8 other firms) among Fintech advisors. Behind that share, the index tracks 275 Fintech deals in all, and 28 of them (10%) name an advisor.

1 priced Fintech deal carry Houlihan Lokey's name, with a median of $4B, which is above the Fintech median of $231M across 45 priced deals in the sector.

Houlihan Lokey's Fintech credits are TRAFiX (Trading Technologies International, Sep 30, 2026, Undisclosed); Accelerant (Thoma Bravo, Aug 13, 2026, $4B).

For the full Fintech picture beyond Houlihan Lokey, see Fintech M&A Deals (2026) and Fintech sector record (JSON).

Healthtech: Houlihan Lokey against the sector

Houlihan Lokey is credited on 2 of the 16 advised Healthtech deals, a 12% share, which puts Houlihan Lokey #1 of 19 (tied with 3 other firms) among Healthtech advisors. Behind that share, the index tracks 142 Healthtech deals in all, and 16 of them (11%) name an advisor.

1 priced Healthtech deal carry Houlihan Lokey's name, with a median of $59.5M, which is below the Healthtech median of $259M across 18 priced deals in the sector.

Houlihan Lokey's Healthtech credits are Icario (Vitality Group International, Sep 3, 2026, $59.5M); CareSeed (Sagility, Jun 12, 2026, Undisclosed).

For the full Healthtech picture beyond Houlihan Lokey, see Healthtech sector record (JSON).

SaaS: Houlihan Lokey against the sector

Houlihan Lokey is credited on 2 of the 66 advised SaaS deals, a 3.0% share, which puts Houlihan Lokey #10 of 70 (tied with 9 other firms) among SaaS advisors. Behind that share, the index tracks 477 SaaS deals in all, and 66 of them (14%) name an advisor.

No SaaS deal credited to Houlihan Lokey published terms, so Houlihan Lokey has no median to set against the sector median of $175.5M across 44 priced deals.

Houlihan Lokey's SaaS credits are Queue-It (THL, Aug 18, 2026, Undisclosed); Apploi (Viventium, Feb 4, 2026, Undisclosed).

For the full SaaS picture beyond Houlihan Lokey, see SaaS M&A Deals (2026) and SaaS sector record (JSON).

Data infrastructure: Houlihan Lokey against the sector

Houlihan Lokey is credited on 1 of the 27 advised Data infrastructure deals, a 3.7% share, which puts Houlihan Lokey #5 of 35 (tied with 30 other firms) among Data infrastructure advisors. Behind that share, the index tracks 196 Data infrastructure deals in all, and 27 of them (14%) name an advisor.

No Data infrastructure deal credited to Houlihan Lokey published terms, so Houlihan Lokey has no median to set against the sector median of $114M across 36 priced deals.

Houlihan Lokey's Data infrastructure credits are Anova (Aurora Capital Partners, Jan 22, 2026, Undisclosed).

For the full Data infrastructure picture beyond Houlihan Lokey, see Data infrastructure sector record (JSON).

Vertical AI: Houlihan Lokey against the sector

Houlihan Lokey is credited on 1 of the 13 advised Vertical AI deals, a 7.7% share, which puts Houlihan Lokey #1 of 13 (tied with 12 other firms) among Vertical AI advisors. Behind that share, the index tracks 271 Vertical AI deals in all, and 13 of them (4.8%) name an advisor.

No Vertical AI deal credited to Houlihan Lokey published terms, so Houlihan Lokey has no median to set against the sector median of $125M across 44 priced deals.

Houlihan Lokey's Vertical AI credits are Sudolabs (Eldridge, Aug 10, 2026, Undisclosed).

For the full Vertical AI picture beyond Houlihan Lokey, see Vertical AI M&A Deals (2026) and Vertical AI sector record (JSON).

What Houlihan Lokey's targets look like

The businesses Houlihan Lokey advised on are described in the index as equities order and execution management systems, member engagement and behavioral health platform, virtual waiting room and queue management software, data-driven risk exchange for specialty insurance, custom agentic AI systems, enterprise consulting, HEDIS quality reporting and analytics for payers, healthcare hiring and workforce management software and IIoT remote asset monitoring platform.

Across Houlihan Lokey's 8 credited rows the tags that recur most are agentic ai, ai deployment, behavioral health, chart abstraction, cloud platform, e-commerce infrastructure, enterprise ai and equities.

Target countries recorded for Houlihan Lokey's deals: the United States (5), Denmark (1) and Slovakia (1), known for 7 of 8 rows.

Buyer countries recorded for Houlihan Lokey's deals: the United States (6), known for 6 of 8 rows.

2 deals in Houlihan Lokey's record are flagged cross-border, 2 of them on the US and Europe corridor.

Directory profile and reviews

  • Location: New York, NY
  • Founded: 1972
  • Employees: 2500+
  • Minimum engagement size: $10M
  • Services: M&A Advisory, Capital Markets, Financial Restructuring, Fairness Opinions and Valuation

The directory describes Houlihan Lokey this way: Leading global investment bank specializing in M&A, capital markets, and financial restructuring. Ranked #1 M&A advisor for deal count for multiple years.

Google Business Profile shows 5 stars from 7 reviews for the listing named Houlihan Lokey, checked on Oct 7, 2026 (open the listing on Google Maps).

Directory metrics for Houlihan Lokey: directory rank #1, deal volume of $380 billion as listed, domain authority 72, domain rating 76 and AI visibility score 94. These come from ProCloser's own directory data, not from the deal index.

Full listing: Houlihan Lokey in the ProCloser directory.

Firms credited in the most of the same sectors as Houlihan Lokey, nearest in credited-deal count first. Names link to a profile only where the firm has one.

  • J.P. Morgan: 5 sectors in common with Houlihan Lokey (Data infrastructure, Fintech, Healthtech, SaaS and Vertical AI), 21 credited deals against 8 for Houlihan Lokey
  • KPMG: 4 sectors in common with Houlihan Lokey (Data infrastructure, Fintech, Healthtech and SaaS), 6 credited deals against 8 for Houlihan Lokey
  • Jefferies: 4 sectors in common with Houlihan Lokey (Data infrastructure, Fintech, Healthtech and SaaS), 13 credited deals against 8 for Houlihan Lokey
  • Barclays: 3 sectors in common with Houlihan Lokey (Data infrastructure, Fintech and SaaS), 7 credited deals against 8 for Houlihan Lokey
  • William Blair: 3 sectors in common with Houlihan Lokey (Data infrastructure, Healthtech and SaaS), 7 credited deals against 8 for Houlihan Lokey

Machine-readable record for Houlihan Lokey

The same credits as structured data, with an evidence label on every row: JSON record and Markdown record. Both are licensed CC BY 4.0 and rebuilt daily with this page.

Frequently asked questions about Houlihan Lokey

How many deals is Houlihan Lokey credited on in this index?

Houlihan Lokey is credited on 8 deals: 6 sell-side and 2 buy-side, announced between Jan 22, 2026 and Sep 30, 2026. The targets are Anova, Apploi, CareSeed, Sudolabs, Accelerant and Queue-It and others. 2 of the 8 disclosed a price. That count covers only deals verified by the ProCloser index, each with a public source naming Houlihan Lokey, and is not the firm's full track record.

Which sectors does Houlihan Lokey advise in?

Houlihan Lokey is credited in Fintech (2), Healthtech (2), SaaS (2), Data infrastructure (1) and Vertical AI (1). Fintech is the largest at 2 of 8 credited deals (25%). The index tracks 11 sectors in total, so Houlihan Lokey appears in 5 of them.

What is the largest deal Houlihan Lokey was credited on?

The largest priced deal in Houlihan Lokey's record is Thoma Bravo acquiring Accelerant for $4 billion, announced Aug 13, 2026 (News). The median price across Houlihan Lokey's 2 priced deals is $2.03 billion.

Is Houlihan Lokey mostly a sell-side or a buy-side advisor?

Houlihan Lokey is sell-side on 6 of 8 credited deals (75%) and buy-side on 2 (25%). Across all 378 credits in the index, 59% are sell-side, so Houlihan Lokey is more sell-side heavy than the league as a whole.

Which acquirers has Houlihan Lokey worked with?

Houlihan Lokey has worked on deals involving 8 acquirers. The most frequent in Houlihan Lokey's record: Thoma Bravo (1), Vitality Group International (1) and Aurora Capital Partners (1). Buyer types: strategic (4), private equity (3) and public company (1).

How does Houlihan Lokey rank against the typical advisor in the league table?

Houlihan Lokey is #7 of 174 by credited deals, against a league median of 1 credited deal. By total disclosed value Houlihan Lokey is #17 of 58 among firms with a priced deal. Rankings reflect public credits in this index only and undercount firms that rarely announce their deals.

Where does the data on Houlihan Lokey come from?

Each of the 8 credits for Houlihan Lokey links to a public source, split by type as news (6) and press release (2). A firm is credited only when its name appears in that source text; we do not add credits for Houlihan Lokey from memory or from third-party databases.

Which firms advised alongside Houlihan Lokey?

7 other firms appear on the same deals as Houlihan Lokey, led by Marks Baughan (1), Morgan Stanley (1) and Baird (1). 4 of 8 deals credited to Houlihan Lokey name another advisor.

How do I get an introduction to a firm like Houlihan Lokey?

If you are selling a Fintech company or another software business, get matched and ProCloser will introduce you to a vetted M&A advisory firm that fits your sector and deal size, free to sellers. Houlihan Lokey is one of 174 firms credited in the index and ranks #7 of 174 by credited deals.

Selling a software company?

Get matched with the right advisor for your deal.

The advisors credited in this index work deals like yours every quarter. Tell us about your company and we will match you with a vetted M&A advisory firm in your sector and size range, including success-fee-only options. Free to sellers.

Get matched free